NCT00045565View on ClinicalTrials.gov

Arsenic Trioxide Plus Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

October 31, 2002

Primary Completion Date

November 30, 2008

Conditions
Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma
Interventions
DRUG

arsenic trioxide

Given IV

RADIATION

radiation therapy

Undergo radiation therapy

Trial Locations (1)

21231-1000

New Approaches to Brain Tumor Therapy Consortium, Baltimore

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00045565 - Arsenic Trioxide Plus Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma | Biotech Hunter | Biotech Hunter